北美的心血管設備市場：投資分析與成長機會 是由出版商Frost & Sullivan在2006年05月所出版的。
這份英文市場調查報告書價格從美金4950起跳。
專門於高科技領域之顧問服務與市場調查的美國調查公司 Frost & Sullivan （總公司：德州），針對北美心血管設備市場進行調查分析，經系統整理後出版報告書 "North American Cardiovascular Devices Market - Investment Analysis and Growth Opportunities" 。
本報告書內容包括：北美心血管設備市場之市場簡介與成長機會、投資分析、財務標竿以及企業購併趨勢等。內容綱要摘記如下：
第1章 實施概要
第2章 簡介及方法論
第3章 投資分析與成長機會
- 市場簡介
- 產業經濟學
- 投資分析與成長機會
- 投資項目
- 價值鏈分析
- 領域別得分卡
- 企業的投資機會得分卡
- Frost & Sullivan 心血管設備成長監視器
第4章 財務標竿與價值衡量
- Frost & Sullivan 心血管設備領域
- 比例分析
- 與去年比銷售成長趨勢
- 銷售總值收益率
- 一般管理費用佔銷售總額比例
- 研發費用佔銷售總額比例
- 單位員工收益
- 平均總資產收益率 對 平均股東資本收益率
- 設備投資佔銷售總額比例
- 流動率
- 現金入帳日與付款日
- 庫存資產周轉率
- 運轉資本比率
- 資產周轉率
- 規模分析
- 固定費用分析
- 價值衡量
- 根據銷售總額及利益所做的逐年評價
- EV ／ LTM 銷售總額變化
- 累計股價表現
- Frost & Sullivan 心血管設備指南
- 產業成長可能性
- EPS 影響分析
- 未上市股票及創投業者？
- 企業購併
Abstract
Research Overview
Frost & Sullivan's Medical Devices Financial Benchmarking & Analysis (FBA) service presents a broad financial outline of the medical devices industry, highlighting major market and financial trends in key growth segments. It provides a comprehensive financial analysis of leading medical devices firms to support the investment and financial analysis needs of decision makers in the marketplace. The current study within the service focuses on the following key growth sectors of the North American Cardiovascular Devices Market: cardiac rhythm management, interventional cardiology, and cardiac surgery.
Increased Consolidation and Improved Prospects for Venture Capital Investors
The North American Cardiovascular Devices Industry is characterized by a relatively fewer number of participants that are on an aggressive acquisition spree. With the acquisition of Guidant by Boston Scientific, the space is consolidating further. Moreover, smaller companies that develop technologies catering to an unmet need, or that convert a surgery from an in-patient to an out-patient setting, have historically been the takeover targets by larger companies. Against such backdrop, this study aims to address issues such as: the impact of consolidation on venture capital investments in the industry, the effect of the consolidation on the exit market for venture capitalists, the IPO market as an exit strategy for venture capital investors, and the segments that demonstrate significant growth potential and are attracting increased interest.
Rise in Number of Out-Patient Surgeries Providing Additional Investment Opportunities
There is an increasing preference in the market for minimally invasive surgeries amongst patients as well as doctors. These surgeries are associated with lesser trauma, shorter recovery time, and lesser post operative pain. Cardiologists also stand to gain from this trend, as more surgeries can be performed at a given time.Thus, any technology that could convert a surgery from an in-patient to an outpatient setting is considered to be a good investment and is welcomed by the market.
Table of Contents
1 EXECUTIVE SUMMARY
2 INTRODUCTION AND METHODOLOGY
3 INVESTMENT ANALYSIS AND GROWTH OPPORTUNITIES
- Market Overview
- Introduction
- Cardiac Rhythm Management
- Interventional Cardiology
- Cardiac Surgery
- Industry Economics
- Investment Analysis and Growth Opportunity
- Investment Themes
- Value Chain Analysis
- Sector Scorecard
- Company Investment Opportunity Scorecard
- Frost & Sullivan Cardiovascular Devices Growth Monitor
4 FINANCIAL BENCHMARKING AND VALUATION
- Frost & Sullivan Cardiovascular Devices Universe
- Ratio Analysis
- Year-over-Year Sales Growth
- Operating Margin
- Selling General and Administrative (SGA) Expenses to Sales
- Research and Development (R&D) to Sales
- Revenues per Employee
- Return on Average Assets vs. Return on Average Equity
- Capital Expenditure (Capex) to Sales
- Current Ratio
- Receivable and Payable Days
- Inventory Turnover Ratio
- Working Capital Ratio
- Asset Turnover Ratio
- Common Size Analysis
- Fixed Cost Analysis
- Valuations
- Historical Valuation based on Sales and Profitability
- EV / LTM Sales Trend
- Year to Date Stock Performance
- Frost & Sullivan Cardiovascular Devices Index
- Industry Growth Outlook
- EPS Impact Analysis
- Private Equity and Venture Capital Activity
- Mergers and Acquisitions
